Unified Barlow Protocol (UP) in Cancer Survivors for Cognitive Impairments

Background: Cognitive impairment appears frequently in cancer survivors, negatively affecting the quality of life and emotional well-being of patients. This study compares the effectiveness of a well-established treatment (cognitive rehabilitation) with the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP) to alleviate these cognitive deficits and evaluate its effect on anxiety-depressive symptoms and the quality of life of survivors. Methods: A three-arm randomized superiority clinical trial, with a pre-post and follow-up repeated measures and intergroup design with

Trial Details

NCT ID
NCT05289258
Phase
NA
Sponsor
Universidad de Córdoba
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • Neuropsychological treatment
  • Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders (PU).
  • Waitlist group
Locations (sample)
  • Córdoba, Córdoba, Spain|37.89155,-4.77275
  • Córdoba, Córdoba, Spain|37.89155,-4.77275

Key Eligibility Criteria

  • Cancer diagnosis, stages I-III.
  • Cancer type: Breast.
  • Have received the last chemotherapy session in the last 6 months and a maximum of 6 years of treatment completion.
  • Probable or mild to moderate cognitive impairment (score between 26 and 10 points according to the MMSE).

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →